日付 |
時間 |
ソース |
タイトル |
2024/5/04 | 03:14 | BW | CORRECTING and REPLACING Aditxt Announces Pricing of $4.2.. |
2024/5/03 | 22:00 | BW | Aditxt Announces Pricing of $4.2 Million Private Placement.. |
2024/4/02 | 21:30 | BW | Aditxt Signs a Definitive Agreement to Acquire Appili.. |
2024/3/27 | 21:36 | PRNUS | Evofem Reports $18.2 million of Phexxi Net Product Sales in.. |
2024/3/12 | 05:51 | EDGAR2 | Form 8-K - Current report |
2024/3/07 | 21:54 | PRNUS | For Women Using GLP-1 Receptor Agonists who take Oral Birth.. |
2024/3/05 | 07:27 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
2024/3/05 | 07:24 | EDGAR2 | Form 8-K - Current report |
2024/3/02 | 06:01 | EDGAR2 | Form 8-K - Current report |
2024/3/01 | 06:01 | EDGAR2 | Form 8-K - Current report |
2024/2/23 | 07:21 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
2024/2/22 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/2/17 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/2/16 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/2/14 | 23:26 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
2024/2/10 | 06:31 | EDGAR2 | Form 8-K - Current report |
2024/2/07 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/2/03 | 06:28 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
2024/2/03 | 06:26 | EDGAR2 | Form 8-K - Current report |
2024/2/01 | 22:00 | PRNUS | Evofem Biosciences Announces Strong Preliminary Results,.. |
2024/1/31 | 07:28 | EDGAR2 | Form 8-K - Current report |
2024/1/31 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/1/30 | 22:30 | BW | Aditxt, Inc. Acquires Proprietary Electroencephalography.. |
2024/1/24 | 06:18 | EDGAR2 | Form D - Notice of Exempt Offering of Securities |
2024/1/20 | 06:15 | EDGAR2 | Form 8-K - Current report |
2024/1/19 | 06:30 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
2024/1/10 | 07:19 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
2024/1/10 | 07:16 | EDGAR2 | Form 8-K - Current report |
2024/1/08 | 22:30 | BW | Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life.. |
2024/1/06 | 06:30 | EDGAR2 | Form 8-K - Current report |
2024/1/05 | 22:45 | EDGAR2 | Form 8-K - Current report |
2024/1/05 | 22:30 | BW | Aditxt Announces Closing of $6.0 Million Private Placement.. |
2024/1/02 | 22:45 | EDGAR2 | Form 8-K - Current report |
2024/1/02 | 22:30 | BW | Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’.. |
2023/12/30 | 07:07 | BW | Aditxt Announces $6 Million Private Placement Priced.. |
2023/12/27 | 07:26 | EDGAR2 | Form 8-K - Current report |
2023/12/23 | 07:00 | EDGAR2 | Form 8-K - Current report |
2023/12/23 | 06:30 | EDGAR2 | Form 8-K - Current report |
2023/12/22 | 06:30 | EDGAR2 | Form 8-K - Current report |
2023/12/13 | 07:09 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
2023/12/13 | 07:04 | EDGAR2 | Form 8-K - Current report |
2023/12/12 | 22:30 | BW | Aditxt, Inc. Enters into Definitive Agreement to Acquire.. |
2023/12/09 | 06:05 | EDGAR2 | Form 8-K - Current report |
2023/12/02 | 06:39 | EDGAR2 | Form 8-K - Current report |
2023/11/17 | 06:30 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2023/11/14 | 06:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/14 | 06:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/14 | 06:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/14 | 06:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/10 | 06:30 | EDGAR2 | Form 8-K - Current report |